Retinoic acid for treatment of multicentric Castleman's disease.
Multicentric Castleman's syndrome has an aggressive course with poor prognosis, and its treatment remains uncertain. We report a woman with multicentric Castleman's disease that was successfully treated with prednisone and retinoic acid.
Rieu
P
P
Droz
D
D
Gessain
A
A
Grünfeld
J P
JP
Hermine
O
O
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D005871:Castleman Disease / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D011241:Prednisone / Q000627:therapeutic use*; D014212:Tretinoin / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D014212:Tretinoin; D011241:Prednisone